glp-1 agonist review receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease Mapping the effectiveness and risks

Rapid weight loss with GLP1 receptor agonists can come at the cost of skeletal muscle, potentially undermining metabolic and functional outcomes

Evaluate the benefits and concerns surrounding GLP-1 treatments

Experts warn that misuse of Ozempic and Mounjaro could trigger serious health risks without medical supervision.

Research suggests that foods, such as eggs, vegetables, and olive oil, may help increase GLP-1 levels

A lower, fixed dose for those who want a gentle, mindful, cosmetic approach rather than full dose weight loss

In late 2025, a seemingly narrow advertising dispute told a much bigger story about the GLP-1 market